Back to Newsroom

Sigilon Therapeutics to Present at Upcoming September Conferences

CAMBRIDGE, Mass.Sept. 7, 2017 /PRNewswire/ — Sigilon Therapeutics, a biopharmaceutical company that discovers and develops immune-privileged living therapeutic implants, today announced the company will present at the following conferences in September.
READ MORE…